GLP-1 Medication
— Oral Semaglutide (Rybelsus)

As GLP-1 receptor agonists gain traction in weight-management and metabolic care, oral semaglutide — marketed as Rybelsus® — offers a unique non-injectable option driven by the same hormone-modulating science found in injectable GLP-1 drugs like Ozempic and Wegovy.

Oral Semaglutide (Rybelsus) daily tablets in blister pack packaging
Oral semaglutide Singapore comes in 3mg, 7mg and 14mg dosages

What Is Oral Semaglutide (Rybelsus)?

Rybelsus® (oral semaglutide) is a once-daily tablet containing semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. This medication was originally approved for type 2 diabetes to improve blood sugar control, but its appetite-modulating properties also support weight loss under medical supervision. GLP-1 medications mimic a hormone naturally produced in the gut, helping the body:

These mechanisms support a caloric deficit and help many patients lose weight when combined with lifestyle changes.

Oral Semaglutide (Rybelsus) daily tablets in blister pack packaging (2)
Oral Semaglutide reduces blood sugar levels and suppresses appetite for weight loss

How Oral Semaglutide Works

Oral semaglutide activates the GLP-1 pathway in the gut and brain to regulate hunger, enhance fullness, and improve glucose metabolism. Because it’s taken as a daily tablet, its absorption depends on how and when it’s taken relative to food and liquids (proper administration maximises its effectiveness).

Dosage & Administration

Rybelsus tablets are available in several strengths — typically 3 mg, 7 mg, and 14 mg — and are generally stepped up gradually to improve tolerability.

How to take Rybelsus:

These steps help maximise absorption in the stomach.

If a dose is missed, skip it and resume the next day — do not double up.

Medical illustration representing 1024x683 in a clinical setting

Effectiveness for Weight Management

Clinical evidence shows that oral semaglutide can support meaningful weight reduction when paired with a balanced diet and physical activity. In trial data, patients taking higher doses have shown noticeable weight loss compared to placebo, although results tend to be more modest than weekly injectable GLP-1 options like Wegovy or Mounjaro.

Typical outcomes reported in Singapore practice indicate several-percent reductions in body weight over months of daily use, with individual results varying.

Oral Semaglutide (Rybelsus) daily tablets in blister pack packaging
Clinical illustration relating to glp 1 medication

Safety & Side Effects

Oral semaglutide shares a similar side-effect profile with other GLP-1 medications. Common, generally mild effects include:

These symptoms often improve after the first few weeks as your body adjusts.

More serious but less common risks include pancreatitis or gallbladder issues — particularly in individuals with relevant histories — so clinical oversight is important.

Who Might Be a Good Candidate

Daily oral semaglutide can be a suitable choice for people who:

In Singapore, a clinician will assess your health profile and goals before prescribing Rybelsus.

Rybelsus may not be suitable for people who are pregnant or breastfeeding, those with a history of certain thyroid cancers, or individuals with specific gastrointestinal conditions — consult your doctor for personalised advice.

Medical illustration representing 1024x713 in a clinical setting

How Rybelsus Fits Within the GLP-1 Landscape

GLP-1 receptor agonists now come in several forms:

Each has pros and cons, and your doctor can help decide which matches your lifestyle and treatment goals best.

Summary — Key Points on Oral Semaglutide

Aspect Rybelsus (Oral Semaglutide)
Medication Type
GLP-1 receptor agonist tablet
Administration
Once daily on an empty stomach
Main Uses
Type 2 diabetes; weight management under supervision
Appetite Effects
Reduces hunger, slows stomach emptying
Weight Loss
Effective, generally modest vs injectables
Side Effects
GI-related, usually transient
Suitability
Adults with guidance from a clinician

Frequently Asked Questions

Rybelsus is a once-daily oral tablet containing semaglutide, a GLP-1 receptor agonist. Originally approved for managing type 2 diabetes, its appetite-modulating properties also support weight management when prescribed under medical supervision. It serves as a non-injectable alternative to other GLP-1 medications.

GLP-1 medications work by mimicking a hormone naturally produced in the gut that regulates metabolic function. This helps to increase insulin secretion, slow down stomach emptying, and suppress appetite. When combined with dietary changes and physical activity, these mechanisms can support a caloric deficit for weight management.

Rybelsus must be taken once daily in the morning on an empty stomach to maximize its absorption and effectiveness. You should swallow the tablet with a small sip of water (no more than 120ml) and wait at least 30 minutes before eating, drinking, or taking other medications. If a dose is missed, skip it and resume your normal schedule the next day.

Oral semaglutide offers the convenience of a daily tablet, whereas injectable GLP-1 medications are typically administered once a week. While clinical data indicates oral semaglutide is effective for weight management, the results are generally more modest compared to higher-dose weekly injections like Mounjaro or Wegovy. Your doctor will help determine which administration method aligns with your medical profile.

Like other GLP-1 medications, Rybelsus can cause gastrointestinal side effects such as nausea, vomiting, bloating, diarrhoea, or constipation. These effects are usually mild and improve after the first few weeks of treatment. Less common but serious risks, such as pancreatitis or gallbladder issues, require clinical oversight.

Suitable candidates typically include adults seeking a medically supervised weight management strategy who prefer taking a daily tablet over receiving injections. Rybelsus may not be appropriate for individuals who are pregnant, breastfeeding, or those with a history of specific gastrointestinal or thyroid conditions. A doctor’s assessment is required to ensure the medication is safe for you.

Contact Us

Book An Appointment Now

Take the first step toward a healthier, more confident you. Our medical team is ready to answer your questions and guide you through safe, personalised weight-loss options. Reach out today to schedule a consultation or speak with our care specialists.